Navigation Links
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512,in Restless Legs Syndrome

trials for XP13512, and the results thereof; the uncertainty of the FDA approval process and other regulatory requirements; the therapeutic and commercial value of the company's compounds; and issues relating to regulatory approval, manufacturing and commercialization of XP13512. These and other risk factors are discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2006, filed with the Securities and Exchange Commission on March 7, 2007. XenoPort expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

XenoPort is a registered U.S. trademark.

Source code: XNPT2C

Contact

XenoPort, Inc.
Jackie Cossmon, 408-616-7220
ir@XenoPort.com


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:12/15/2009)... 15 Today, Hill-Rom Holdings, Inc. (NYSE: ... progress on significant strategic and financial initiatives at ... The Conference is hosted by Peter H. Soderberg, ... presentations on the following topics: ,, Status ... and development and financial updates Smart technologies ...
(Date:12/15/2009)... -- Genomic Health, Inc. (Nasdaq: GHDX ) today ... type DX® breast cancer test, a multi-gene expression ... of chemotherapy benefit and recurrence risk for patients with ... 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held ... ,, "The breadth of data presented at last week,s ...
(Date:12/15/2009)... Mass., Dec. 15 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that an ... factor for three-quarters of surveyed European oncologists in ... of Avastin for the treatment of breast cancer. ... Forum report entitled European Trends in Targeted ...
Breaking Medicine Technology:Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 53950 1Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 53950 2EMBO pioneers pension plan for internationally mobile postdoctoral researchers 9517 1EMBO pioneers pension plan for internationally mobile postdoctoral researchers 9517 2EMBO pioneers pension plan for internationally mobile postdoctoral researchers 9517 3Navigating in the ocean of molecules 9514 1Navigating in the ocean of molecules 9514 2Navigating in the ocean of molecules 9514 3
... a Winning Pursuit, WASHINGTON, Dec. 19 ... President, Foundation for Biomedical,Research:, Biomedical research the ... in 1980 earned Mario Capecchi a Nobel Prize ... Harvard-educated genetics professor,persisted toward his goal. Within four ...
... 19 - When cholesterol-clogged,plaque narrows an artery that feeds ... tiny blood vessels in the heart. As these so-called ... reroute some,of the blood flow around the blockage. Scientists ... to develop and prosper, but without,great success. However, you ...
Other Medicine Technology:Nobel Prize-Winning Discovery 2Nobel Prize-Winning Discovery 3Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes 2
(Date:12/15/2009)... how will they get paid for patient care? Capture,s medical ... , ... Washington, DC (Vocus) December 15, ... codes. These codes are what healthcare providers submit to ... medical consultation, whether in a provider’s office or hospital setting. ...
(Date:12/15/2009)... America,s premier manufacturer of Spa, Massage, and Medical tables announces ... an adjustable breast comfort system to ease pressure felt while ... ... New Freedom, Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, ... equipment, today announced the launch of the Utopian Massage Table ...
(Date:12/15/2009)... Ill. A study in the Dec. 15 issue ... shows that being overweight or obese increases the risk ... not in younger children. , Results indicate ... years of age and older increased 3.5 fold with ... while the risk of OSA did not significantly increase ...
(Date:12/14/2009)... carry oxygen, drugs, and more… , ... ... Barbara, in collaboration with scientists at University of Michigan, have ... functions of natural red blood cells, including softness, flexibility, and ... ,The primary function of natural red blood cells is to ...
(Date:12/14/2009)... Heska Corporation (Nasdaq: HSKA ... provider of veterinary diagnostic and specialty products, ... the Company,s new DRI-CHEM® 7000 Veterinary Chemistry ... http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, Customers receiving these analyzers ... chemistry analyzer available to the veterinary in-clinic ...
Breaking Medicine News(10 mins):Health News:Medicare Eliminates Consultation Codes for Doctors 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3
... 10 According to the American,Diabetes Association there ... States who have diabetes and approximately one million ... 2007, 17.5 million diagnosed,diabetics in the U.S. resulted ... response to this growing epidemic, Health Management Corporation,(HMC), ...
... Oklahoma and Louisiana, MINERAL WELLS, Texas, Nov. ... and bottled by Famous Mineral Water Co. in ... Foods Market,locations across Texas, Oklahoma and Louisiana. This ... of the only domestically bottled mineral,water available in ...
... HI ) will announce its fourth-quarter earnings results ... text of the release and,financials will be available on ... company will hold a conference call and simultaneous webcast ... ET. The webcast is,available through the Investor Relations section ...
... But researchers are working on new therapies to combat the ... of U.S. children allergic to foods such as peanuts, milk ... researchers are working on new approaches to treating these allergies, ... American College of Allergy, Asthma and Immunology,s annual meeting, in ...
... Initial Physician Experience with Eculizumab in Patients ... Presented, CHESHIRE, Conn., Nov. 10 ... announced that the American,Society of Hematology (ASH) ... as a treatment for patients with paroxysmal,nocturnal ...
... 10 TransTech Services Partners,Inc. (OTC Bulletin Board: ... Dr. Ranga C. Krishna as a director at ... licensed neurologist and an experienced,health care entrepreneur, having ... Inc., a company which assists U.S.,pharmaceutical companies perform ...
Other Medicine News:Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 2Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 3Health News:Crazy Water Expands Distribution to Whole Foods Market(R) 2Health News:Crazy Water Expands Distribution to Whole Foods Market(R) 3Health News:Childhood Food Allergies on the Rise 2Health News:Childhood Food Allergies on the Rise 3Health News:Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting 2Health News:Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting 3Health News:Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting 4
DNA/RNA preparation in 384-well format...
... refrigerator -4C. 5.2 Cubic ... Interior light. Manual push ... drawers. Two shelves. In-door ... Adjustable thermostat. Magnetic gasket. ...
... Alternative to Bottled Water, The Simplicity personal ... laboratories that currently use bottled water. In ... ship and store bottled water, your laboratory ... contamination can be absorbed from containers and ...
... Produces up to 12 L/min of Type ... On Demand, The Super-Q Plus System is ... water which has been pretreated by reverse ... consistently produce ultrapure water quality which exceeds ...
Medicine Products: